These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20561353)

  • 41. In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting.
    Björkman S; Folkesson A; Berntorp E
    Haemophilia; 2007 Jan; 13(1):2-8. PubMed ID: 17212717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.
    White GC; Shapiro AD; Kurczynski EM; Kim HC; Bergman GE
    Thromb Haemost; 1995 May; 73(5):779-84. PubMed ID: 7482403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radioactive synoviorthesis in patients with hemophilia with factor inhibitor.
    Löfqvist T; Petersson C; Nilsson IM
    Clin Orthop Relat Res; 1997 Oct; (343):37-41. PubMed ID: 9345203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A commentary on the differences in pharmacokinetics between recombinant and plasma-derived factor IX and their implications for dosing.
    Björkman S
    Haemophilia; 2011 Mar; 17(2):179-84. PubMed ID: 21299739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparing prophylaxis with episodic treatment in haemophilia A: implications for clinical practice.
    Manco-Johnson M
    Haemophilia; 2007 Sep; 13 Suppl 2():4-9. PubMed ID: 17685917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prophylaxis in people with haemophilia.
    Coppola A; Franchini M; Tagliaferri A
    Thromb Haemost; 2009 Apr; 101(4):674-81. PubMed ID: 19350110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Results of a cooperative programme of profilactic treatment for haemophilia A and B (author's transl)].
    Sangre (Barc); 1978; 23(5B):780-92. PubMed ID: 725718
    [No Abstract]   [Full Text] [Related]  

  • 49. Chromogenic analysis of FIX activity in haemophilia B patients treated with nonacog beta pegol.
    Young G; Ezban M; Clausen WHO; Negrier C; Oldenburg J; Shima M
    Haemophilia; 2017 Nov; 23(6):e528-e530. PubMed ID: 28922522
    [No Abstract]   [Full Text] [Related]  

  • 50. Insight into health-related quality of life of young children with haemophilia B treated with long-acting nonacog beta pegol recombinant factor IX.
    Carcao M; Kearney S; Santagostino E; Oyesiku JOO; Young NL; Meunier J; Hoxer CS; Zhang C; Blanchette VS
    Haemophilia; 2017 May; 23(3):e222-e224. PubMed ID: 28371032
    [No Abstract]   [Full Text] [Related]  

  • 51. Factor IX inhibitors: Clinical and laboratory profiles of two patients with severe haemophilia B.
    Saini S; Croteau SE; Horling FM; Dunn AL
    Haemophilia; 2019 Mar; 25(2):e126-e129. PubMed ID: 30817051
    [No Abstract]   [Full Text] [Related]  

  • 52. EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in France.
    Polack B; Calvez T; Chambost H; Rothschild C; Goudemand J; Claeyssens S; Borel-Derlon A; Bardoulat I; Maurel F; Woronoff-Lemsi MC;
    Transfusion; 2015 Jul; 55(7):1787-97. PubMed ID: 25652955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prophylaxis use among males with haemophilia B in the United States.
    Ullman M; Zhang QC; Grosse SD; Recht M; Soucie JM;
    Haemophilia; 2017 Nov; 23(6):910-917. PubMed ID: 28780772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Posterior vertebral column resection in a 10-year-old boy with haemophilia B and congenital kyphosis--a case report and literature review.
    Zhang J; Wang S; Weng X; Li Q
    Haemophilia; 2014 Sep; 20(5):e364-7. PubMed ID: 25102760
    [No Abstract]   [Full Text] [Related]  

  • 55. The use of a highly purified factor IX (FIX) concentrate in patients with 'haemophilia B' undergoing surgery.
    Ho PJ; Rickard KA
    Aust N Z J Med; 1995 Feb; 25(1):43-5. PubMed ID: 7786245
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database.
    Puetz J; Soucie JM; Kempton CL; Monahan PE;
    Haemophilia; 2014 Jan; 20(1):25-31. PubMed ID: 23855900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe haemophilia B revealed by intracranial hemorrhage in a newborn.
    Ben Ameur S; Tiss O; Sfaihi L; Chabchoub I; Aloulou H; Kamoun T; Hachicha M
    Tunis Med; 2015 May; 93(5):330-1. PubMed ID: 26578055
    [No Abstract]   [Full Text] [Related]  

  • 58. Subcutaneous factor IX administration to patients with hemophilia B.
    Berrettini M; Iorio P; Nenci GG; Arcieri P; Mariani G
    Am J Hematol; 1994 Sep; 47(1):61-2. PubMed ID: 8042620
    [No Abstract]   [Full Text] [Related]  

  • 59. Association between haemophilia and inherited thrombophilia: a single centre survey.
    Di Perna C; Franchini M; Riccardi F; Rivolta GF; Angeri F; Tagliaferri A
    Haemophilia; 2011 Jan; 17(1):161-2. PubMed ID: 20642788
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy of factor IX Grifols(®) in surgery: experience of an international multicentre retrospective study.
    Pérez-Garrido R; Alonso N; Jiménez-Yuste V; Haya S; Zúñiga P; Baques A; Candela M; Dávoli M; Rescia V
    Haemophilia; 2012 Sep; 18(5):e372-3. PubMed ID: 22845857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.